MedTrace Logo

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

NCT01836042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2016-04-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.

Conditions

  • Primary Open Angle Glaucoma

Sponsors & Collaborators

  • Glaukos Corporation

    lead INDUSTRY

Principal Investigators

  • Jeff Wells, PharmD, MBA · Glaukos Corporation

  • Jay Katz, MD · Wills Eye Institute; Thomas Jefferson University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01836042 on ClinicalTrials.gov